Allergy Therapeutics^ (AGY): PQ Birch Phase III recruitment completed (BUY) | 4imprint^ (FOUR): Lower US tax enhances EPS and cash generation (BUY)
09 Jan 2018
Morning Note
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
- Published:
09 Jan 2018 -
Author:
Guy Hewett | Mark Brewer | Cavendish Research -
Pages:
4
Allergy Therapeutics^ (AGY): PQ Birch Phase III recruitment completed (BUY) | 4imprint^ (FOUR): Lower US tax enhances EPS and cash generation (BUY)